37
Views
11
CrossRef citations to date
0
Altmetric
Review

Social, economic, and health utility considerations in the treatment of overactive bladder

, , , , , , , & show all
Pages 11-24 | Published online: 11 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Carlo Gandi & Emilio Sacco. (2021) Pharmacological Management of Urinary Incontinence: Current and Emerging Treatment. Clinical Pharmacology: Advances and Applications 13, pages 209-223.
Read now
Hadi Mostafaei, Shahrokh F. Shariat, Hanieh Salehi-Pourmehr, Florian Janisch, Keiichiro Mori, Fahad Quhal & Sakineh Hajebrahimi. (2020) The clinical pharmacology of the medical treatment for overactive bladder in adults. Expert Review of Clinical Pharmacology 13:7, pages 707-720.
Read now
Shang-Jun Wu, Yu-Qiong Xu, Zheng-Yan Gao, Zhi-Peng Wang, Feng Zhao, Lin Liu & Sheng Wang. (2019) Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis. Renal Failure 41:1, pages 937-945.
Read now
Riccardo Bientinesi & Emilio Sacco. (2018) Managing urinary incontinence in women - a review of new and emerging pharmacotherapy. Expert Opinion on Pharmacotherapy 19:18, pages 1989-1997.
Read now
Zalmai Hakimi, Jameel Nazir, Charles McCrea, Malin Berling, Francis Fatoye, Barbara Ramos & Adrian Wagg. (2017) Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in Canada. Journal of Medical Economics 20:6, pages 614-622.
Read now
Konstantinos Giannitsas & Anastasios Athanasopoulos. (2015) A review of cost–effectiveness comparisons for overactive bladder treatments: which is the most cost-effective for improving quality of life?. Expert Review of Pharmacoeconomics & Outcomes Research 15:3, pages 413-423.
Read now
Craig A Mayr & Jonathan P Shepherd. (2014) Cost–effectiveness of novel therapies for overactive bladder. Expert Review of Pharmacoeconomics & Outcomes Research 14:4, pages 527-535.
Read now
Emilio Sacco, Riccardo Bientinesi, Daniele Tienforti, Marco Racioppi, Gaetano Gulino, Daniele D'Agostino, Matteo Vittori & Pierfrancesco Bassi. (2014) Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence. Expert Opinion on Drug Discovery 9:4, pages 433-448.
Read now
Janet Colli. (2011) Editorial foreword. Open Access Journal of Urology 3, pages 121-122.
Read now

Articles from other publishers (2)

Michelle M. Kim, Joshua Harvey, Andrew Gusev, Jenna M. Norton, Saadia Miran & Tamara Bavendam. (2022) A Scoping Review of the Economic Burden of Non-Cancerous Genitourinary Conditions. Urology 166, pages 29-38.
Crossref
Arsenie Spinu, Ovidiu Bratu, Camelia Diaconu, Ana Stanescu, Simona Bungau, Ovidiu Fratila, Roxana Bohiltea & Dan Mischianu. (2020) Botulinum toxin in low urinary tract disorders ‑ over 30 years of practice (Review). Experimental and Therapeutic Medicine.
Crossref